Singapore markets close in 7 hours 4 minutes
Straits Times Index
3,384.69 +6.40 (+0.19%) Nikkei
27,409.92 -23.48 (-0.09%) Hang Seng
22,273.99 +204.26 (+0.93%) FTSE 100
7,784.87 +19.72 (+0.25%) BTC-USD
22,860.21 -817.73 (-3.45%) CMC Crypto 200
518.76 -19.11 (-3.55%)
InMode Ltd. (INMD)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EST
After hours:
| Previous close | 35.48 |
| Open | 35.12 |
| Bid | 34.41 x 1200 |
| Ask | 34.56 x 900 |
| Day's range | 34.42 - 35.35 |
| 52-week range | 20.60 - 54.68 |
| Volume | |
| Avg. volume | 1,287,325 |
| Market cap | 2.864B |
| Beta (5Y monthly) | 2.19 |
| PE ratio (TTM) | 16.34 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- CNW Group
InMode Receives Health Canada Certification of Forma-I for Dry Eye Disease Due to Meibomian Gland Dysfunction
InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, is proud to announce the Health Canada license of the Forma-I to address the symptoms of dry eye disease due to Meibomian gland dysfunction (MGD). Forma-I is intended for use in the periorbital area and eyelids and relieves inflammation of meibomian glands and eye irritation.
© 2023 Yahoo. All rights reserved.
